ConductScience.org, home

Paper2001981

Structure of lactacystin, a new microbial metabolite which induces differentiation of neuroblastoma cells.

Omura S and 6 others. J Antibiot (Tokyo), 1991. Cited by 217 papers, by iCite.

Cite this record

ConductScience Library. Structure of lactacystin, a new microbial metabolite which induces differentiation of neuroblastoma cells. Papers, record 2001981. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2001981

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Structure of lactacystin, a new microbial metabolite which induces differentiation of neuroblastoma cells.
PubMed
Journal
J Antibiot (Tokyo)
PubMed
Year
1991
PubMed
Publication types
Letter
PubMed
Citations, by iCite
217
iCite
Relative citation ratio, by iCite
5.62
iCite
Revised in PubMed
2019-07-23
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Omura SS
2Matsuzaki KK
3Fujimoto TT
4Kosuge KK
5Furuya TT
6Fujita SS
7Nakagawa AA

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
NeuronsMajor topic
Acetylcysteine
Cell Differentiation
Magnetic Resonance Spectroscopy
Molecular Conformation
Molecular Structure
Neuroblastoma
Streptomyces
Tumor Cells, Cultured
X-Ray Diffraction

Source PubMed

Download CSV of topics

Cited by44

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 217 citations.

PMIDTitleJournalYearIn PapersSource
41220833Synthetic study toward vibralactone.Beilstein J Org Chem2025https://conductscience.org/library/papers/41220833PubMed
40874681Nickel-Catalyzed Carbonylative Cyclization of Bromodifluoroacetamides with Arylboronic Acids toward δ-Lactams.Org Lett2025https://conductscience.org/library/papers/40874681PubMed
40819216Ubiquitination dynamics in human tumour viruses: Viral infection, oncogenesis and antiviral therapy.FEBS J2026https://conductscience.org/library/papers/40819216PubMed
39806036Biosynthesis of lactacystin as a proteasome inhibitor.Commun Chem2025https://conductscience.org/library/papers/39806036PubMed
38784729Thiophene-fused γ-lactams inhibit the SARS-CoV-2 main protease via reversible covalent acylation.Chem Sci2024https://conductscience.org/library/papers/38784729PubMed
36173301Host Cell Neddylation Facilitates Alphaherpesvirus Entry in a Virus-Specific and Cell-Dependent Manner.Microbiol Spectr2022https://conductscience.org/library/papers/36173301PubMed
35531531Formal synthesis of (+)-lactacystin from l-serine.RSC Adv2019https://conductscience.org/library/papers/35531531PubMed
34767710Enzymatic Cβ-H Functionalization of l-Arg and l-Leu in Nonribosomally Derived Peptidyl Natural Products: A Tale of Two Oxidoreductases.J Am Chem Soc2021https://conductscience.org/library/papers/34767710PubMed
33791679Natural product scaffolds as inspiration for the design and synthesis of 20S human proteasome inhibitors.RSC Chem Biol2020https://conductscience.org/library/papers/33791679PubMed
31936021Screening for Sulfur Compounds by Molybdenum-Catalyzed Oxidation Combined with Liquid Chromatography-Mass Spectrometry.Molecules2020https://conductscience.org/library/papers/31936021PubMed
30755736Lactacystin: first-in-class proteasome inhibitor still excelling and an exemplar for future antibiotic research.J Antibiot (Tokyo)2019https://conductscience.org/library/papers/30755736PubMed
30029468(-)-Homosalinosporamide A and Its Mode of Proteasome Inhibition: An X-ray Crystallographic Study.Mar Drugs2018https://conductscience.org/library/papers/30029468PubMed
28196975Tyropeptins, proteasome inhibitors produced by Kitasatospora sp. MK993-dF2.J Antibiot (Tokyo)2017https://conductscience.org/library/papers/28196975PubMed
25730728The marine actinomycete genus Salinispora: a model organism for secondary metabolite discovery.Nat Prod Rep2015https://conductscience.org/library/papers/25730728PubMed
25491896Streptomyces lactacystinicus sp. nov. and Streptomyces cyslabdanicus sp. nov., producing lactacystin and cyslabdan, respectively.J Antibiot (Tokyo)2015https://conductscience.org/library/papers/25491896PubMed
24784133Natural compounds as next-generation herbicides.Plant Physiol2014https://conductscience.org/library/papers/24784133PubMed
24353244Neurotrophic natural products: chemistry and biology.Angew Chem Int Ed Engl2014https://conductscience.org/library/papers/24353244PubMed
23181572From bortezomib to other inhibitors of the proteasome and beyond.Curr Pharm Des2013https://conductscience.org/library/papers/23181572PubMed
22021939Sporolide B: Synthetic Studies.Tetrahedron2011https://conductscience.org/library/papers/22021939PubMed
21916437Stereospecific total syntheses of proteasome inhibitors omuralide and lactacystin.J Org Chem2011https://conductscience.org/library/papers/21916437PubMed

See all 44 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2001981

GET https://conductscience.org/api/papers/v1/2001981/cited_by?page=2